Iovance Biotherapeutics (IOVA) earnings, Nov 5, 2026: EPS +80%, stock −11.0%
In brief
Iovance Biotherapeutics reported on Nov 5, 2026. Earnings per share changed +80% year over year, 40.5% above the estimate; revenue +80%. The stock opened with a −3.4% gap and closed the day −11.0% (Nov 5, 2026). The stock is now 49.6% below its 52-week high, +327.6% over 12 months.
EPS vs estimate+40.5%
EPS, YoY+80%
Revenue, YoY+80%
Gap · day−3.4% · −11.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2026 | +37.1% | +43.1% |
| Nov 5, 2026 | −3.4% | −11.0% |
Next-quarter estimates, ratings and the IOVA chart are in the terminal.
Open the terminalFAQ
When is Iovance Biotherapeutics's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did Iovance Biotherapeutics stock react to the report?
Opening gap −3.4%, day's result −11.0%.
Did Iovance Biotherapeutics's earnings grow?
Earnings per share rose 80% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.